&Partners’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Sell
43,045
-103,561
-71% -$1.26M ﹤0.01% 1859
2026
Q1
$1.77M Buy
146,606
+33,031
+29% +$452K 0.01% 964
2025
Q4
$1.61M Buy
113,575
+78,994
+228% +$1.12M 0.01% 965
2025
Q3
$493K Buy
34,581
+21,238
+159% +$318K ﹤0.01% 1453
2025
Q2
$188K Buy
+13,343
New +$205K ﹤0.01% 1845

Other funds holding CCAP

&Partners's CCAP Position: Q2 2026 in Review

&Partners reduced its Crescent Capital BDC (CCAP) stake by 71% in Q2 2026, selling an estimated $1.26M and leaving 43,045 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

&Partners first reported a position in CCAP in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.77M in Q1 2026. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.

  • &Partners held 43,045 shares of Crescent Capital BDC worth $470K as of Q2 2026.
  • &Partners sold 103,561 Crescent Capital BDC shares in Q2 2026, an estimated $1.26M.
  • Crescent Capital BDC made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1859 holding.
  • &Partners first reported a position in Crescent Capital BDC in Q2 2025 and has held it in 5 quarters since.
  • &Partners's Crescent Capital BDC position peaked at $1.77M in Q1 2026.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.